Arachidonoyl Glycine – 10 mg

Brand:
Cayman
CAS:
179113-91-8
Storage:
-80
UN-No:
De Minimis - 1170 / 3

Arachidonoyl glycine (N-arachidonyl glycine; NAGly) has been isolated from cell cultures treated with arachidonoyl ethanolamide (AEA; anandamide),{9578} from extracts of mammalian brain,{9579,9589} and has also been synthesized as an analog of AEA for structure/activity testing.{9580} NAGly may be produced endogenously via oxidation of AEA, or by transacylation of arachidonoyl CoA. NAGly is reported to have analgesic activities in whole animal experiments.{9578,9579,9589} Since it seems to be a very poor ligand for the CB1 receptor,{9580} these effects are probably mediated via other signaling pathways.  

 

Available on backorder

SKU: 90051 - 10 mg Category:

Description

Produced endogenously via oxidation of AEA, or by transacylation of arachidonoyl CoA; has analgesic activities in whole animal experiments, yet is a very poor ligand for the CB1 receptor


Formal name: N-[1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl]-glycine

Synonyms:  N-Arachidonyl Glycine|NAGly

Molecular weight: 361.5

CAS: 179113-91-8

Purity: ≥98%

Formulation: A solution in ethanol